Full info forABBOTT
| Application ID | 1-1765-99580 |
| Status | IE Pass |
| Prioritization Number | 1344 |
| TLD (#13) | ABBOTT |
| IDN Translation (#14b) | -- |
| Applicant (#1) | Abbott Laboratories |
| Website (#5) | http://www.abbott.com |
| Application Type | |
| Type | Standard |
| Contested | no |
| Contested Numbers | 1 |
| GAC Early Warning | no |
| Cultural, Linguistic or Religious | no |
| dotBrand | yes |
| Trademark Class A | class 5 (pharma, dietetic food) |
| Trademark Class B | |
| Trademark Class C | |
| Industry Keyword | healthcare |
| Remark | Abbott Laboratories (“Abbott”) is a global, diversified healthcare company devoted to the discovery, development, manufacture, and marketing of pharmaceuticals, nutritional products, and medical products including devices, diagnostic tests, and instruments. |
| Availability Data | |
| Sunrise Period: | fromunknown tounknown |
| Landrush Period: | fromunknown tounknown |
| GoLive: | unknown |
| Registration Policy | |
| Restricted | yes |
| Restrictions | dotbrand |
| Backend Provider | Afilias |
| Registry Website | |
| Keyword | |
| Keyword | no |
| English Meaning | -- |
| Appeal Ranking | 0 |
| Appeal Remark | Reserved for company and affiliate use only. |
| English | not applicable |
| Spanish | not applicable |
| Portuguese | not applicable |
| French | not applicable |
| Italian | not applicable |
| German | not applicable |
| Dutch | not applicable |
| Swedish | not applicable |
| Danish | not applicable |
| Mandarin | not applicable |
| Russian | not applicable |
| Location | |
| Region | North America |
| Country | United States |
| Community (#19) | -- |
| Geographic (#21a) | -- |
| Geographic Category | -- |
| IDN | |
| IDN (#14) | No |
| A-label (#14a) | -- |
| Translation (#14b) | -- |
| Script Code (#14d) | -- |
| Allows ASCII | yes |
| Applicant | |
| Applicant (#1) | Abbott Laboratories |
| Website (#5) | http://www.abbott.com |
| Applicant Address (#2) | 100 Abbott Park Road Abbott Park Illinois 60064 United States [US] |
| Applicant Phone (#3) | +1 847 937 6100 |
| Applicant Fax (#4) | +1 847 937 3675 |
| Legal Form (#8) | Corporation |
| Exchange Symbol (#9a) | New_York_Stock_Exchange |
| Parent Company (#9b) | |
| Joint Venture Partners (#9c) | |
| Primary Contact | |
| Name (#6) | Philip Lodico |
| Title (#6) | Managing Partner |
| e-mail (#6) | lodico.ab@fairwindspartners.com |
| Secondary Contact | |
| Name (#7) | Dirk Hoerter |
| Title (#7) | Director, Digital Marketing Excellence |
| e-mail (#7) | dirk.hoerter@abbott.com |
| Mission / Purpose (#18a) | |
| 18.1 Mission and Purpose of .ABBOTT Abbott Laboratories (“Abbott”) is a global, diversified healthcare company devoted to the discovery, development, manufacture, and marketing of pharmaceuticals, nutritional products, and medical products including devices, diagnostic tests, and instruments. Abbott has sales, manufacturing, research and development, and distribution facilities around the world and is well-recognized for its global reach. Abbott employs over 90,000 people and has an online presence in over 75 countries. Its online content is accessible in the .COM gTLD and also in multiple ccTLDs. A sample of the ccTLDs in which Abbott posts content is as follows: .COM.AR, .COM.AU, .COM.CN, .DK, .FR, .DE, .CO.IN, .IE, JP, .NO, .ES, .CO.UK, .CA, and .US. Abbott Laboratories manufactures and distributes numerous products around the world in the following categories: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. For more information, see: http:⁄⁄www.abbottinvestor.com⁄. Through a unified corporate approach, Abbott intends to submit two gTLD applications for the .ABBOTT and .ABBVIE gTLDs. The intended future mission and purpose of the .ABBOTT gTLD is to serve as a trusted, hierarchical, and intuitive namespace provided by Abbott and its subsidiaries for its consumers. Abbott Laboratories is the designated entity to file this application and bring the .ABBOTT gTLD to market. Therefore, although Abbott is committed to moving forward with the .ABBOTT gTLD application, at the time of filing Abbott does not believe that there has been enough time or market information available to fully analyze and evaluate all potential use case options. Thus, Abbott is planning for a limited use of the .ABBOTT gTLD initially, with the possibility of expanding as market information becomes available and Abbott’s digital strategy develops. Abbott will be analyzing and evaluating other .BRAND gTLD applications, as well as general market adoption, to determine short- and long-term potential best use case options to more effectively serve and enhance Abbott’s online strategy as a leading global diversified healthcare company. Abbott intends to initially limit registration and use of domain names within the .ABBOTT gTLD to Abbott and its qualified subsidiaries and affiliates. This initial limited use will allow Abbott to establish its operations and achieve full sustainability. This limited distribution, coupled with the other requirements set forth in Specification 9 of the template Registry Agreement, is intended to exempt Abbott from its annual Code of Conduct Compliance requirements. After Stage 3 (below), Abbott will evaluate whether opportunities exist to carry out the business strategy for the .ABBOTT gTLD through expansion that continues the sustainable operations of the registry through fee-based registrations to parties other than Abbott and its qualified subsidiaries and affiliates. Abbott currently plans a four-stage rollout for the .ABBOTT gTLD: 1. Stage 1 The initial stage of implementation of the gTLD will involve Abbott registering a limited number of .ABBOTT second-level domain names. This initial use will provide Abbott’s IT and security personnel the time to run a number of tests to ensure seamless and secure access using the .ABBOTT gTLD domain names, interoperability with various software and Web-based applications, and unbroken and secure use of all names. This initial allocation will also allow the appropriate Abbott staff to coordinate with the internal and external staff responsible for the application, delegation, and setup phases of the .ABBOTT gTLD to ensure a proper transition from delegation to full operation. 2. Stage 2 Once all testing has been successfully completed, Abbott will begin allocating domain names in the .ABBOTT gTLD for more widespread internal corporate use. During this same period of time, Abbott will begin evaluating strategies to potentially migrate traffic away from its current network of second-level domain names, which are registered in a variety of TLDs, to Abbott’s new gTLDs. It is in Stage 2 that Abbott will evaluate expanding the operations of the gTLD to permit registration by other registrants, such as licensees or other strategic parties. Should an assessment of its expansion strategy lead to a decision to extend registration rights to other parties, Abbott is currently planning for this expansion to take place during Stage 3. However, any expansion would be dependent upon a review of Specification 9 (Registry Code of Conduct) set forth in the template Registry Agreement to ensure compliance with Abbott’s business model. 3. Stage 3 Depending upon the analysis of the evaluations undertaken in stage two, Abbott may begin to implement the migration of Internet traffic away from the TLDs in which Abbott’s domain names are currently registered, and toward the .ABBOTT gTLD. It is in this stage that Abbott also may implement its decision to extend registration rights to licensees or strategic parties depending upon compliance with Specification 9 as noted above. The dates of such expansion are subject to change depending upon business, strategic, and industry factors at the time. After consideration of the following factors: analysis of Abbott’s existing domain name portfolio; internal analysis of marketing initiatives; and the fact that Abbott will have full control over the number of registrations in the .ABBOTT gTLD namespace, Abbott is confident that the number of domain name registrations will be less than 10,000 in the first five years of operation. 4. Stage 4 Based on its experience with any expansion implemented in Stage 3, Abbott will assess whether its business plan and expansion strategy should be augmented by extending registration rights to a broader class of licensees, potentially including customers of Abbott. It is anticipated by Abbott that changes to the domain name industry, and particularly the impact of .BRAND gTLDs, will take at least five years to be realized and assessed. Any decision to expand the gTLDs beyond corporate, qualified subsidiary and affiliate, and licensee use will take into account this experience as well as the technical analysis of potential expansion. The potential use of the .ABBOTT gTLD by Abbott and its various business segments will also be driven by Abbott’s future business strategies as identified in its annual report and investor filings, see: http:⁄⁄www.abbottinvestor.com⁄. Utilizing current projections based upon Abbott’s existing businesses, future business plans, current domain name portfolio, and other strategic factors, Abbott estimates that second-level domain name registrations will be in line with the projections set forth in the financial template provided in response to Question 46 of this application. |
|
If you wish to download the application information pertaining to this new gTLD, please select your download preference below: 1) A PDF compilation of the information provided by eBrand Services will be generated for you.; 2) The public portion of the application made available by ICANN will be generated.
Be informed about the status of applicationABBOTT
Do you want to be kept up to date with the application status for a domain under a new gTLD?
We understand that the roll out of the new gTLD’s is a long process and you may be undecided on the specific domain you wish to pursue. Nonetheless, if you would like to be informed about the progress of a particular new gTLD, and all essential elements (policies, pricing, launch schedules, and registration deadlines), request a follow up and join our watchlist. Alternatively, let us review your business/situation and supply you with a customized solution fitting your individual needs.
File an objection for applicationABBOTT
eBrand Services has designed a series of defensive approaches to ensure that rightholders can object applications of new gTLD that affect their interests asserting prior rights over certain string or Trademark. Contact us to know more:
Express your interest for a domain name under the extensionABBOTT
An Expression of Interest allows you to submit a non-binding interest in registering the specific domains most relevant to you. By doing so, we can provide you with up-to-date information about launch schedules, pricing, policies, and ensure you avoid missing registration deadlines. Prior to the release of your domain name under a new gTLD, we will let you know and we can assist you in turning your Expression of Interest into a binding registration order, or cancel your Expression of Interest. Whilst we will endeavor to secure your desired domain for you, please note that we cannot guarantee a successful registration. It is important to acknowledge that multiple registration phases will take place. For more information, please refer our FAQ’s. All Expression of Interest’s are free of charge and legally non-binding.
Additionally, let us review your business/situation and supply you with a customized solution fitting your individual needs.
Contact us to know more: